Customer publications – B-205
← Return to all publications
S. M. Sarrett, O. Keinänen, E. J. Dayts, G. Dewaele-Le Roi, C. Rodriguez, K. E. Carnazza, B. M. Zeglis. Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy
Nat Protoc, vol. 16, 2021, pp. 3348-3381
J. Ren, M. Xu, J. Chen, J. Ding, P. Wang, L. Huo, F. Li, Z. Liu. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a ¹⁷⁷Lu-labeled αPD-L1 antibody
Theranostics, vol. 11, 2021, pp. 304-315
Y. Funase, E. Nakamura, M. Kajita, Y. Saito, S. Oshikiri, M. Kitano, M. Tokura, A. Hino, T. Uehara. Preclinical Characterization of the Radioimmunoconjugate ¹¹¹In or ⁹⁰Y-FF-21101 Against a P-Cadherin-Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate
J Nucl Med, vol. 62, 2021, pp. 232-239
C. A. Ferreira, L. Kang, C. Li, A. Kamkaew, K. E. Barrett, E. Aluicio-Sarduy, Y. Yang, J. W. Engle, D. Jiang, W. Cai. ImmunoPET of the differential expression of CD146 in breast cancer
Am J Cancer Res, vol. 11, 2021, pp. 1586-1599
Q. Cao, Q. Huang, Y. A. Wang, C. Li. Abraxane-induced bone marrow CD11b(+) myeloid cell depletion in tumor-bearing mice is visualized by μPET-CT with ⁶⁴Cu-labeled anti-CD11b and prevented by anti-CSF-1
Theranostics, vol. 11, 2021, pp. 3527-3539
A. Pichard, S. Marcatili, J. Karam, J. Constanzo, R. Ladjohounlou, A. Courteau, M. Jarlier, N. Bonnefoy, S. Patzke, V. Stenberg, P. Coopman, G. Cartron, I. Navarro-Teulon, A. Repetto-Llamazares, H. Heyerdahl, J. Dahle, M. Bardiès, J. P. Pouget. The therapeutic effectiveness of ¹⁷⁷Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest
Leukemia, vol. 34, 2020, pp. 1315-1328
A. Karimian, N. T. Ji, H. Song, G. Sgouros. Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy
Cancer Res, vol. 80, 2020, pp. 868-876
W. Dawicki, K. J. H. Allen, R. Garg, E. M. Geoghegan, M. S. Berger, D. L. Ludwig, E. Dadachova. Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy
Oncotarget, vol. 11, 2020, pp. 3571-3581
D. L. J. Thorek, A. T. Ku, N. Mitsiades, D. Veach, P. A. Watson, D. Metha, S. E. Strand, S. K. Sharma, J. S. Lewis, D. S. Abou, H. G. Lilja, S. M. Larson, M. R. McDevitt, D. Ulmert. Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer
Clin Cancer Res, vol. 25, 2019, pp. 881-891
O. A. Marcos-Contreras, J. S. Brenner, R. Y. Kiseleva, V. Zuluaga-Ramirez, C. F. Greineder, C. H. Villa, E. D. Hood, J. W. Myerson, S. Muro, Y. Persidsky, V. R. Muzykantov. Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain
J Control Release, vol. 301, 2019, pp. 54-61
A. F. Maaland, H. Heyerdahl, A. O'Shea, B. Eiriksdottir, V. Pascal, J. T. Andersen, A. Kolstad, J. Dahle. Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate (177)Lu-NNV003
Eur J Nucl Med Mol Imaging, vol. 46, 2019, pp. 2311-2321
Y. Liang, Q. Liu, Y. Zhou, S. Chen, L. Yang, M. Zhu, Q. Wang. Counting and Recognizing Single Bacterial Cells by a Lanthanide-Encoding Inductively Coupled Plasma Mass Spectrometric Approach
Anal Chem, vol. 91, 2019, pp. 8341-8349
Q. Cao, Q. Huang, C. Mohan, C. Li. Small-Animal PET/CT Imaging of Local and Systemic Immune Response Using ⁶⁴Cu-αCD11b
J Nucl Med, vol. 60, 2019, pp. 1317-1324
Q. Yin, L. Tang, K. Cai, X. Yang, L. Yin, Y. Zhang, L. W. Dobrucki, W. G. Helferich, T. M. Fan, J. Cheng. Albumin as a Trojan Horse for polymeric nanoconjugate transendothelial transport across tumor vasculatures for improved cancer targeting
Biomater Sci, vol. 6, 2018, pp. 1189-1200
L. Henderson, O. Neumann, C. Kaffes, R. Zhang, V. Marangoni, M. K. Ravoori, V. Kundra, J. Bankson, P. Nordlander, N. J. Halas. Routes to Potentially Safer T(1) Magnetic Resonance Imaging Contrast in a Compact Plasmonic Nanoparticle with Enhanced Fluorescence
ACS Nano, vol. 12, 2018, pp. 8214-8223
E. Deshayes, R. Ladjohounlou, P. Le Fur, A. Pichard, C. Lozza, V. Boudousq, S. Sevestre, M. Jarlier, R. Kashani, J. Koch, J. Sosabowski, J. Foster, N. Chouin, F. Bruchertseifer, A. Morgenstern, P. O. Kotzki, I. Navarro-Teulon, J. P. Pouget. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
J Nucl Med, vol. 59, 2018, pp. 1234-1242